Viewing StudyNCT06388889



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06388889
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-04-29
First Post: 2024-03-27

Brief Title: Phase III Long-Term Extension Study With Dexpramipexole
Sponsor: Areteia Therapeutics
Organization: Areteia Therapeutics

Conditions & Keywords Data

Conditions:
Name
Eosinophilic Asthma
Keywords:
Name View
Asthma Attack View
Exacerbations View
Severe Asthma View
EXHALE-2 View
EXHALE-3 View
EXHALE-4 View
Uncontrolled Asthma View